Insmed Incorporated (INSM)

The Nasdaq-100 Index has announced its annual reconstitution, with six new companies being added and six being removed, effective December 22, 2025....

Castleark Management LLC trimmed its position in shares of Insmed, Inc. (NASDAQ: INSM) by 94.2% in the undefined quarter, according to its most recent disclosure with the SEC. The institutional invest...

Alkeon Capital Management LLC purchased a new stake in shares of Insmed, Inc. (NASDAQ: INSM) during the second quarter, according to the company in its most recent 13F filing with the Securities and E...

California Public Employees Retirement System lessened its position in Insmed, Inc. (NASDAQ: INSM) by 16.3% in the second quarter, according to the company in its most recent filing with the Securitie...

Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been winning....

BRIDGEWATER, N.J. , Dec. 4, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform...

American Century Companies Inc. lowered its stake in shares of Insmed, Inc. (NASDAQ: INSM) by 78.2% during the second quarter, according to the company in its most recent Form 13F filing with the Secu...

Insmed Incorporated (INSM) Presents at Evercore 8th Annual Healthcare Conference Transcript...

Druckenmiller invests his personal and family's wealth through his fund, the Duquesne Family Office. Druckenmiller is high on biotech stocks, with his top three holdings at the end of the third quarte...

Insmed, Inc. (NASDAQ: INSM - Get Free Report) shares hit a new 52-week high during trading on Wednesday. The company traded as high as $209.77 and last traded at $209.02, with a volume of 2093177 shar...